Depressive Disorder, Major: all 2,805 studies
Page 23 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Mental Health Telemetry for Self-Management in Major DepressionCompletedNCT01999010Not applicable
- Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive DisorderStatus unknownNCT01997580Phase 4
- Effect of Physical Activity on Depressive Symptoms With a 5 Month Follow-upCompletedNCT01995422Not applicable
- Pilot Study Assessing Computerized Cognitive Behavioral Therapy for DepressionCompletedNCT01990053Not applicable
- Computerized Cognitive Remediation for Geriatric DepressionStatus unknownNCT01979289Not applicable
- A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive DisorderStatus unknownNCT01977378Phase 2/3
- Deep Brain Stimulation in Patients With Chronic Treatment Resistant DepressionCompletedNCT01973478Not applicable
- Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)CompletedNCT01962753Not applicable
- Detecting Depression and Bipolar Disorder in Adolescents Using a Biomarker PanelTerminatedNCT01957501
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field StudyWithdrawnNCT01944657Not applicable
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
- A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant TreatmentCompletedNCT01941043Phase 2
- Cognitive Training for DepressionCompletedNCT01936506Phase 1/2
- Cognitive Training for Depression IICompletedNCT01934491Not applicable
- Vitamin D, SSRIs and the Musculoskeletal SystemCompletedNCT01932931Not applicable
- Oral Multiple-dose Study in Patients With Major Depressive DisorderCompletedNCT01924520Phase 1
- Deep Brain Stimulation in Treatment Refractory DepressionTerminatedNCT01921543Phase 1/2
- Blame Rebalance fMRI Feedback Proof-of-conceptCompletedNCT01920490Not applicable
- Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive DisorderCompletedNCT01919008Phase 1
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome PatientsWithdrawnNCT01916200Phase 4
- Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)CompletedNCT01912196Phase 2
- A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)CompletedNCT01909232Not applicable
- Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive DisorderCompletedNCT01903200Phase 1
- Escitalopram, Placebo and tDCS in Depression: a Non-inferiority TrialCompletedNCT01894815Phase 3
- Maintenance Transcranial Electrical Stimulation for DepressionCompletedNCT01890356Not applicable
- A Health Intervention to Prevent Depression Hepatitis C PatientsTerminatedNCT01890083Phase 2/3
- Randomized Controlled Trial of Conventional vs Theta Burst rTMSCompletedNCT01887782Not applicable
- Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant TrialCompletedNCT01887639
- Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood DisordersCompletedNCT01882608Not applicable
- A Randomised Controlled Clinical Trial of Memory Specificity Training (MEST) for DepressionCompletedNCT01882452Not applicable
- Comparison of Two tDCS Protocols for the Treatment of Major Depressive DisorderCompletedNCT01877447Not applicable
- Non-invasive Brain Stimulation and Cognitive Processing in DepressionCompletedNCT01875419Not applicable
- Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive DisorderCompletedNCT01871974Phase 1
- Effects of Sevoflurane and Ketamine on QT in Electroconvulsive TherapyCompletedNCT01870219Phase 4
- Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal LossCompletedNCT01867749Not applicable
- Deep rTMS for Treatment-Resistant Late-life DepressionCompletedNCT01860157Not applicable
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?TerminatedNCT01856127Phase 4
- Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese AmericansCompletedNCT01851967Not applicable
- Cognitive Behavioral Therapy and Interpersonal Psychotherapy as Treatment for Major Depressive DisorderStatus unknownNCT01851915Not applicable
- Brain Inflammation in Major Depressive Disorder BackgroundCompletedNCT01851356
- Identifying Biological Markers for Severe DepressionCompletedNCT01831882
- Lifestyle Intervention for Diabetes and Weight Management in PsychosisCompletedNCT01828931Not applicable
- Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major DepressionCompletedNCT01824433Phase 4
- Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?CompletedNCT01818453Not applicable
- An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety SymptomsCompletedNCT01814098Phase 4
- A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4
- Evaluation of a Stepped Care Approach to Manage Depression in DiabetesCompletedNCT01812291Not applicable
- Effects of Early Abuse on Adult Intimate RelationshipsCompletedNCT01803802Not applicable
- DBS of the Lateral Habenula in Treatment-Resistant DepressionActive, not recruitingNCT01798407Not applicable
- Physician Survey on Monitoring of Patients Treated With QuetiapineCompletedNCT01795326
- EMR Data to Assess Monitoring of Patients Treated With QuetiapineCompletedNCT01793324
- Improving Depression Outcome by Enhancing Memory for Cognitive TherapyCompletedNCT01790919Phase 2
- Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major DepressionCompletedNCT01778790Phase 2
- A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive DisorderTerminatedNCT01774747Phase 1
- Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood DisordersTerminatedNCT01769859
- Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major DepressionStatus unknownNCT01768052
- Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownNCT01764867Phase 4
- Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive DisorderWithdrawnNCT01752608Not applicable
- My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental IllnessCompletedNCT01749124Not applicable
- Genetic and Neural Predictors of Adolescent DepressionCompletedNCT01743716
- Efficacy and Safety Study of ABT-436 in Major Depressive DisorderTerminatedNCT01741142Phase 2
- Brief Multifamily Psychoeducation for Families of Patients With Chronic Major DepressionCompletedNCT01734291Not applicable
- Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive DisorderWithdrawnNCT01733654Phase 2
- Agomelatine in Depressed Patients With FibromyalgiaCompletedNCT01731899
- Self-Management for Anxiety, Depression and Somatoform DisordersCompletedNCT01726387Not applicable
- Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With CancerCompletedNCT01725048Early Phase 1
- Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)CompletedNCT01724112Phase 2
- The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety DisordersCompletedNCT01721824Not applicable
- Neurophysiologic Correlates of HypersomniaCompletedNCT01719315
- Cortical Excitability and Inhibition in MDDCompletedNCT01718730
- Neural Components Underlying the Treatment of Adolescent DepressionCompletedNCT01717508Not applicable
- Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD RecurrenceCompletedNCT01714050Not applicable
- Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone AdministrationCompletedNCT01710202
- Acupuncture for Persistent Insomnia Associated With Major Depressive DisorderCompletedNCT01707706Not applicable
- Effectiveness of Buddhist Monks in Providing Cognitive Behavior TherapyStatus unknownNCT01706731Not applicable
- Depression and Dopamine Transporter Function Study Using C-11 AltropaneCompletedNCT01701141
- Role of Inflammation Factors and Insulin Resistance in Major Depressive DisorderStatus unknownNCT01699490Phase 4
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive DisorderCompletedNCT01696617Phase 4
- Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)CompletedNCT01692574Not applicable
- Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major DepressionCompletedNCT01685294Phase 3
- Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to AntidepressantsCompletedNCT01684163Phase 2
- Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive DisorderStatus unknownNCT01682785
- The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With DepressionStatus unknownNCT01671124
- Major Depressive Disorder (MDD)CompletedNCT01662817
- Dopamine Neurotransmission in Major DepressionCompletedNCT01659814
- Canadian Biomarker Integration Network for Depression StudyCompletedNCT01655706Phase 3
- Modulation of Cognitive Control by Transcranial Direct Current StimulationCompletedNCT01652391Not applicable
- Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderTerminatedNCT01650740Not applicable
- Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive PatientsCompletedNCT01640483Not applicable
- A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant DepressionCompletedNCT01640080Phase 2
- Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male VolunteersCompletedNCT01633437Phase 1
- Whole Body Hyperthermia and Major Depression (MDD)CompletedNCT01625546Not applicable
- Social Cognition in Longstanding PsychosisTerminatedNCT01624831
- Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive DisorderWithdrawnNCT01613820Not applicable
- Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive DisorderCompletedNCT01608399Not applicable
- Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive DisorderCompletedNCT01606384Phase 2
- Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive DisorderCompletedNCT01601210Early Phase 1
- LEPR Polymorphism Weight Gain by Mirtazapine in Late Life DepressionCompletedNCT01601002Phase 4
- Functional and Neurochemical Correlates of Treatment Response in Major Depressive DisorderTerminatedNCT01598324
- European Drug Utilization StudyCompletedNCT01594996